Professor Idit Maya, a senior physician and manager of the Nephrogenetic Clinic and Genomic School for Physicians at Rabin ...
Oncocyte progresses towards FDA authorization for its transplant rejection monitoring test, with top U.S. centers participating in the trial. Oncocyte Corp. has made significant progress in preparing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback